ALS Limited

ALQ

AU000000ALQ6

Business Support Services

Delayed Australian S.E. Other stock markets 08:18:51 23/05/2024 am IST			5-day change	1st Jan Change
14.29 ^AUD	+0.78%		+3.03%	+11.05%

22/05	Jarden Downgrades ALS to Overweight From Buy, Adjusts Price Target to AU$14.90 From AU$13.70	MT
21/05	ALS Statutory Net Profit Plunges 96% in Fiscal 2024, Revenue Up 7%; Shares Rise 5%	MT

ALS Limited Provides Financial Guidance for the Full Year of 2020

November 20, 2019 at 04:00 am IST

ALS Limited provided financial guidance for the full year of 2020. The company provided full year NPAT guidance of $185 million to $195 million is in line with the typical [52 ] to [48 ] first half/second half split.

Latest news about ALS Limited

Jarden Downgrades ALS to Overweight From Buy, Adjusts Price Target to AU$14.90 From AU$13.70	22/05	MT
ALS Statutory Net Profit Plunges 96% in Fiscal 2024, Revenue Up 7%; Shares Rise 5%	21/05	MT
Transcript : ALS Limited, 2024 Earnings Call, May 21, 2024	21/05
ALS Limited Reports Earnings Results for the Full Year Ended March 31, 2024	21/05	CI
Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70	02/04	MT
Jarden Adjusts ALS's Price Target to AU$13.70 from AU$13.80, Keeps at Buy	26/03	MT
ALS to Acquire Nuvisan; Shares Down 5%	25/03	MT
Transcript : ALS Limited, Nuvisan Pharma Holding Gmbh - M&A Call	25/03
ALS Limited agreed to acquire YORK Analytical Laboratories, Inc.	25/03	CI
ALS Limited agreed to acquire Wessling Holding Gmbh & Co.Kg.	25/03	CI
ALS Limited agreed to acquire the remaining 51% stake in Nuvisan Pharma Holding Gmbh.	25/03	CI
Jarden Adjusts ALS' Price Target to AU$13.80 From AU$13.40, Keeps at Buy	22/03	MT
Rimfire Pacific Mining Completes Air Core Drilling at Murga Project	18/03	MT
ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024	20/12	CI
New entries in the Investor Asia portfolio	14/12
Australian Shares Rise as Investors Await US Inflation Data for Rate Hike Clues	14/11	MT
ALS Trims Interim Dividend as Fiscal H1 Profit Declines; CFO to Step Down; Shares Up 6%	14/11	MT
Australian shares rise on broad-based gains; CBA inches higher	14/11	RE
ALS Limited acquired 85.6% stake in Indtech Instruments Private Limited for AUD 18.6 million.	14/11	CI
Transcript : ALS Limited, H1 2024 Earnings Call, Nov 14, 2023	14/11
ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024	14/11	CI
ALS Limited Appoints Heike Truöl as Chief Strategy Officer	14/11	CI
Als Limited Announces Interim Dividend for the Period of Six Months Ending 30 September 2023, Payable on 14 December 2023	14/11	CI
ALS Limited Reports Earnings Results for the Half Year Ended September 30, 2023	14/11	CI
ALS Limited acquired 100% stake in Proanaliz Group of Laboratories for AUD 5.1 million.	09/23/09	CI

Chart ALS Limited

Duration

Period

More charts

Company Profile

ALS Limited is an Australia-based company that is engaged in the provision of professional technical services. The Company provides services primarily in the areas of testing, measurement and inspection, supporting environmental monitoring, food and pharmaceutical quality assurance, and mining and mineral exploration. The Companyâs segments include Commodities and Life Sciences. The Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services, tribology testing services and related analytical testing. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health.

Sector

Business Support Services

Calendar

31/07/2024 - Annual General Meeting

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ALS Limited : At the heart of industries under the microscope

May 03, 2023 at 09:04 pm IST

More Strategies

Ratings for ALS Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.18 AUD

Average target price

14 AUD

Spread / Average Target

-1.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Business Support Services

	1st Jan change	Capi.
ALS LIMITED	+11.05%	4.68B
CINTAS CORPORATION	+16.45%	71.02B
JACOBS SOLUTIONS INC.	+6.22%	17.38B
RB GLOBAL, INC.	+13.63%	13.88B
BUREAU VERITAS SA	+20.42%	13.49B
INTERTEK GROUP PLC	+16.25%	10.07B
TELEPERFORMANCE SE	-18.86%	7.08B
GENPACT LIMITED	-1.24%	6.12B
MAXIMUS, INC.	+2.30%	5.3B
EXLSERVICE HOLDINGS, INC.	+1.00%	5.06B

Other Business Support Services

ALS Limited

Equities

ALQ

AU000000ALQ6

Business Support Services

ALS Limited Provides Financial Guidance for the Full Year of 2020

EPS Revisions